A recent meta‐analysis of 21 RCTs assessing the efficacy of metformin alone or as an add‐on treatment to insulin in women predominantly with gestational diabetes (19 studies) as well as Type 2 diabetes (2 studies) similarly showed an improvement in maternal and infant outcomes and was associated with SGA infants.27 This evidence concerns the gene INS and type 2 diabetes mellitus.